Literature DB >> 26025492

Bone marrow mesenchymal stem cell therapy for voiding dysfunction.

Alice Yu1, Lysanne Campeau.   

Abstract

Lower urinary tract symptoms can significantly impact quality of life. Current standard treatments are not always effective and are associated with complications and side effects. The discovery of stem cells led to research into cell-based therapies for treatment of disorders of voiding dysfunction. Bone marrow mesenchymal stem cells are particularly promising given their ability to differentiate into a variety of cell types. Recent studies have investigated bone marrow stem cells to treat a number of functional voiding pathologies including bladder outlet obstruction, neurogenic bladder, and stress urinary incontinence. Experiments in tissue regeneration have also attempted to create artificial bladders and urethras. The purpose of this article is to critically review the literature regarding the use of bone marrow mesenchymal stem cells in treatment of voiding dysfunction.

Entities:  

Mesh:

Year:  2015        PMID: 26025492     DOI: 10.1007/s11934-015-0516-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  32 in total

1.  Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury.

Authors:  Guanghui Dai; Xuebin Liu; Zan Zhang; Zhijun Yang; Yiwu Dai; Ruxiang Xu
Journal:  Brain Res       Date:  2013-08-12       Impact factor: 3.252

2.  Definitions and criteria for stem cells.

Authors:  Leslie P Weiner
Journal:  Methods Mol Biol       Date:  2008

3.  Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.

Authors:  Roberto Soler; Claudius Füllhase; Ariel Hanson; Lysanne Campeau; Cesar Santos; Karl-Erik Andersson
Journal:  J Urol       Date:  2012-02-17       Impact factor: 7.450

4.  Contribution of bone marrow-derived mesenchymal stem cells to the morphological changes in the bladder after partial outlet obstruction: a preliminary study.

Authors:  Yukiko Kanno; Takahiko Mitsui; Hiroshi Sano; Takeya Kitta; Kimihiko Moriya; Katsuya Nonomura
Journal:  Int J Urol       Date:  2014-03-03       Impact factor: 3.369

5.  Recruitment of bone marrow derived cells to the bladder after bladder outlet obstruction.

Authors:  Stacy T Tanaka; Magaly Martinez-Ferrer; John H Makari; Marcia L Wills; John C Thomas; Mark C Adams; John W Brock; John C Pope; Neil A Bhowmick
Journal:  J Urol       Date:  2009-08-18       Impact factor: 7.450

6.  Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence.

Authors:  Shahar Madjar; Anoop K Sharma; Wayne C Waltzer; Zelik Frischer; Charles L Secrest
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

7.  Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.

Authors:  Saeed Oraee Yazdani; Maryam Hafizi; Ali-Reza Zali; Amir Atashi; Farzad Ashrafi; Amir-Saeed Seddighi; Masoud Soleimani
Journal:  Cytotherapy       Date:  2013-07       Impact factor: 5.414

8.  Costs of urinary incontinence and overactive bladder in the United States: a comparative study.

Authors:  Teh-Wei Hu; Todd H Wagner; Judith D Bentkover; Kristi Leblanc; Steve Z Zhou; Timothy Hunt
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

9.  Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease.

Authors:  Lysanne Campeau; Roberto Soler; Sivanandane Sittadjody; Rajesh Pareta; Masanori Nomiya; Mona Zarifpour; Emmanuel C Opara; James J Yoo; Karl-Erik Andersson
Journal:  J Urol       Date:  2013-08-21       Impact factor: 7.450

10.  Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats.

Authors:  Michelle Cruz; Charuspong Dissaranan; Anne Cotleur; Matthew Kiedrowski; Marc Penn; Margot Damaser
Journal:  Obstet Gynecol Int       Date:  2011-09-21
View more
  2 in total

Review 1.  Stress urinary incontinence in women: Current and emerging therapeutic options.

Authors:  Samer Shamout; Lysanne Campeau
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

2.  Bone marrow mesenchymal stem cells therapy on bilateral pelvic nerve crush-induced voiding dysfunction in rats.

Authors:  Zhou Shen; Qingyu Ge; Deyun Shen; Kaiguo Xia; Jun Xiao
Journal:  Int Urogynecol J       Date:  2022-04-22       Impact factor: 1.932

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.